A Multicenter, Open Labeled, Randomized, Phase III Study Comparing Lopinavir/Ritonavir Plus Atazanavir to Lopinavir/Ritonavir Plus Zidovudine and Lamivudine in Naive HIV-1-Infected Patients: 48-Week Analysis of the LORAN Trial
about
A Multicenter, Open Labeled, Randomized, Phase III Study Comparing Lopinavir/Ritonavir Plus Atazanavir to Lopinavir/Ritonavir Plus Zidovudine and Lamivudine in Naive HIV-1-Infected Patients: 48-Week Analysis of the LORAN Trial
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
A Multicenter, Open Labeled, R ...... ek Analysis of the LORAN Trial
@ast
A Multicenter, Open Labeled, R ...... ek Analysis of the LORAN Trial
@en
type
label
A Multicenter, Open Labeled, R ...... ek Analysis of the LORAN Trial
@ast
A Multicenter, Open Labeled, R ...... ek Analysis of the LORAN Trial
@en
prefLabel
A Multicenter, Open Labeled, R ...... ek Analysis of the LORAN Trial
@ast
A Multicenter, Open Labeled, R ...... ek Analysis of the LORAN Trial
@en
P2093
P2860
P1476
A Multicenter, Open Labeled, R ...... ek Analysis of the LORAN Trial
@en
P2093
A B Jessen
B Kuhlmann
B Salzberger
G M Behrens
K U Ulbricht
R E Schmidt
P2860
P356
10.2174/1874613601105010044
P577
2011-04-22T00:00:00Z